Nanotechnology-based chimeric antigen receptor T-cell therapy in treating solid tumor.

Zuo, Yi-Han; Zhao, Xiao-Ping; Fan, Xing-Xing

Zuo, Yi-Han; Zhao, Xiao-Ping; Fan, Xing-Xing.

Afiliação

Zuo YH; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau Special Administrative Region of China; Department of Cardiology, Boston Children Hospital, Harvard Medical School, Boston, MA, USA.
Zhao XP; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau Special Administrative Region of China.
Fan XX; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau Special Administrative Region of China. Electronic address: xxfan@must.edu.mo.

Pharmacol Res ; 184: 106454, 2022 10.

Article em En | MEDLINE | ID: mdl-36115525

Assuntos

Neoplasias Hematológicas; Neoplasias; Receptores de Antígenos Quiméricos; Terapia Baseada em Transplante de Células e Tecidos; Humanos; Hidrogéis; Imunoterapia Adotiva; Nanotecnologia; Neoplasias/patologia; RNA Mensageiro; Receptores de Antígenos de Linfócitos T; Receptores de Antígenos Quiméricos/genética; Microambiente Tumoral

Palavras-chave

CAR; Nanotechnology; Solid tumor; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google